Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nitric Oxide Gas Inhalation for Prevention of COVID-19 in Healthcare Providers

NCT04312243 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04312243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04312243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nitric Oxide Gas Inhalation for Prevention of COVID-19 in Healthcare Providers
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Terminated
Start date
April 7, 2020
Completion date
January 10, 2022
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infections, healthcare associated infection